Search research articles
Contact Us
Filters
Showing results (151-160 of 202) with videos related to
Page
of 21
Sort By:
Bone Marrow Transplantation
|
January 1, 1996
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia
J Mehta, A Mijović, R Powles, et al.
Tissue Antigens
|
March 22, 2001
Identification of HLA-B*0722
A M Little, S T Cox, M A Hoddinott, et al.
Bone Marrow Transplantation
|
February 5, 2008
Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease
Z Y Lim, A Y L Ho, S Abrahams, et al.
Bone Marrow Transplantation
|
September 22, 2009
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
Z Y Lim, W Ingram, R Brand, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 8, 2001
Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways
A G Buggins, D Milojkovic, M J Arno, et al.
British Journal of Haematology
|
October 1, 1990
Clinicopathological features of acute undifferentiated leukaemia with a stem cell phenotype
F Brito-Babapulle, H Pullon, D M Layton, et al.
Bone Marrow Transplantation
|
April 10, 1999
Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study
S M Kelsey, J M Goldman, S McCann, et al.
Leukemia & Lymphoma
|
August 28, 1998
Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases
R Pawson, D S Richardson, A Pagliuca, et al.
Bone Marrow Transplantation
|
April 5, 2005
Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation
A Mijovic, N Russell, R E Clark, et al.
Leukemia
|
April 22, 2006
A novel MHC-associated proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias
A J Knights, A O Weinzierl, T Flad, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 202) with videos related to
Sort By:
Page
of 21
Bone Marrow Transplantation
|
January 1, 1996
Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia
J Mehta, A Mijović, R Powles, et al.
Tissue Antigens
|
March 22, 2001
Identification of HLA-B*0722
A M Little, S T Cox, M A Hoddinott, et al.
Bone Marrow Transplantation
|
February 5, 2008
Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease
Z Y Lim, A Y L Ho, S Abrahams, et al.
Bone Marrow Transplantation
|
September 22, 2009
Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML
Z Y Lim, W Ingram, R Brand, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 8, 2001
Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways
A G Buggins, D Milojkovic, M J Arno, et al.
British Journal of Haematology
|
October 1, 1990
Clinicopathological features of acute undifferentiated leukaemia with a stem cell phenotype
F Brito-Babapulle, H Pullon, D M Layton, et al.
Bone Marrow Transplantation
|
April 10, 1999
Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study
S M Kelsey, J M Goldman, S McCann, et al.
Leukemia & Lymphoma
|
August 28, 1998
Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases
R Pawson, D S Richardson, A Pagliuca, et al.
Bone Marrow Transplantation
|
April 5, 2005
Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation
A Mijovic, N Russell, R E Clark, et al.
Leukemia
|
April 22, 2006
A novel MHC-associated proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias
A J Knights, A O Weinzierl, T Flad, et al.
Page
of 21